Legochem Biosciences Stock Current Liabilities
141080 Stock | KRW 68,000 100.00 0.15% |
LegoChem Biosciences fundamentals help investors to digest information that contributes to LegoChem Biosciences' financial success or failures. It also enables traders to predict the movement of LegoChem Stock. The fundamental analysis module provides a way to measure LegoChem Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LegoChem Biosciences stock.
LegoChem |
LegoChem Biosciences Company Current Liabilities Analysis
LegoChem Biosciences' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current LegoChem Biosciences Current Liabilities | 11.13 B |
Most of LegoChem Biosciences' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LegoChem Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
In accordance with the recently published financial statements, LegoChem Biosciences has a Current Liabilities of 11.13 B. This is much higher than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The current liabilities for all Republic of Korea stocks is notably lower than that of the firm.
LegoChem Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LegoChem Biosciences' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LegoChem Biosciences could also be used in its relative valuation, which is a method of valuing LegoChem Biosciences by comparing valuation metrics of similar companies.LegoChem Biosciences is currently under evaluation in current liabilities category among related companies.
LegoChem Fundamentals
Return On Equity | -2.16 | |||
Return On Asset | 0.04 | |||
Profit Margin | 0.24 % | |||
Operating Margin | 0.15 % | |||
Current Valuation | 1.09 T | |||
Shares Outstanding | 10.6 M | |||
Shares Owned By Insiders | 19.53 % | |||
Shares Owned By Institutions | 8.26 % | |||
Price To Sales | 9.51 X | |||
Revenue | 32.16 B | |||
Gross Profit | 34.81 B | |||
EBITDA | 12.28 B | |||
Net Income | (23.39 B) | |||
Cash And Equivalents | 29.39 B | |||
Total Debt | 9.41 B | |||
Debt To Equity | 0.40 % | |||
Current Ratio | 8.00 X | |||
Cash Flow From Operations | (42.05 B) | |||
Target Price | 50000.0 | |||
Number Of Employees | 12 | |||
Beta | 0.9 | |||
Market Capitalization | 403.31 B | |||
Total Asset | 293.23 B | |||
Retained Earnings | (38.4 B) | |||
Working Capital | 18.47 B | |||
Current Asset | 29.6 B | |||
Current Liabilities | 11.13 B | |||
Z Score | 25.2 | |||
Net Asset | 293.23 B |
About LegoChem Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LegoChem Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LegoChem Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LegoChem Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in LegoChem Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the LegoChem Biosciences information on this page should be used as a complementary analysis to other LegoChem Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for LegoChem Stock analysis
When running LegoChem Biosciences' price analysis, check to measure LegoChem Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LegoChem Biosciences is operating at the current time. Most of LegoChem Biosciences' value examination focuses on studying past and present price action to predict the probability of LegoChem Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LegoChem Biosciences' price. Additionally, you may evaluate how the addition of LegoChem Biosciences to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |